247 related articles for article (PubMed ID: 9647407)
1. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
Gardell SJ; Sanderson PE
Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
[No Abstract] [Full Text] [Related]
2. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
[TBL] [Abstract][Full Text] [Related]
3. Direct Factor Xa and direct thrombin inhibitors: a clinical trial update.
Turpie AG
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):497-508. PubMed ID: 19562646
[TBL] [Abstract][Full Text] [Related]
4. Novel oral anticoagulants. Part II: direct thrombin inhibitors.
Mehta RS
Expert Rev Hematol; 2010 Jun; 3(3):351-61. PubMed ID: 21082985
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
Bauer KA
Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
[TBL] [Abstract][Full Text] [Related]
6. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
7. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Steffel J; Lüscher TF
J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):616-23. PubMed ID: 19561526
[TBL] [Abstract][Full Text] [Related]
8. Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
Young WB; Sprengeler P; Shrader WD; Li Y; Rai R; Verner E; Jenkins T; Fatheree P; Kolesnikov A; Janc JW; Cregar L; Elrod K; Katz B
Bioorg Med Chem Lett; 2006 Feb; 16(3):710-3. PubMed ID: 16257204
[TBL] [Abstract][Full Text] [Related]
9. Factor Xa inhibitors: today and beyond.
Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
[TBL] [Abstract][Full Text] [Related]
10. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
Dong H; Chen SX; Kini RM; Xu HX
J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors.
Hauptmann J; Kaiser B; Nowak G; Stürzebecher J; Markwardt F
Thromb Haemost; 1990 Apr; 63(2):220-3. PubMed ID: 2363124
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells.
Rosenkranz AC; Schrör K; Rauch BH
Thromb Haemost; 2011 Sep; 106(3):561-2. PubMed ID: 21800011
[No Abstract] [Full Text] [Related]
13. Novel oral anticoagulants.
Khoo CW; Tay KH; Shantsila E; Lip GY
Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
[TBL] [Abstract][Full Text] [Related]
14. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
15. Novel constructs for thrombin inhibition.
Becker RC
Am Heart J; 2005 Jan; 149(1 Suppl):S61-72. PubMed ID: 15644795
[No Abstract] [Full Text] [Related]
16. New oral anticoagulants in atrial fibrillation.
Turpie AG
Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant drugs: what is new?
Kei A; Florentin M; Elisaf M; Liberopoulos E
Int Angiol; 2011 Aug; 30(4):299-320. PubMed ID: 21747349
[TBL] [Abstract][Full Text] [Related]
18. Covalent antithrombin-heparin complexes.
Patel S; Berry LR; Chan AK
Thromb Res; 2007; 120(2):151-60. PubMed ID: 16978685
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants and diet: the potential for interaction.
Kamali F
Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
[No Abstract] [Full Text] [Related]
20. The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins.
Lane DA; Ryan K
J Lab Clin Med; 1990 Aug; 116(2):269-70. PubMed ID: 2394942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
